View Cart (0 items)

Pharmaceutical

Valeant to Buy PharmaSwiss for $481 Million

The New York Times reports, Valeant Pharmaceuticals said it would acquire PharmaSwiss, the maker of generic drugs, for 350 million euros ($481 million). PharmaSwiss, based in Switzerland, has operations in
Read More

FDA Extends Plavix Patent by Six Months

The Associated Press reports that the makers of Plavix, the world''s second best-selling medication, will retain exclusive U.S. marketing rights to the blood thinner for an additional six months, under
Read More

Novartis Bids $470 Million for Cancer Diagnostic Firm Genoptix

Swiss drug maker Novartis AG is paying $470 million to acquire U.S. cancer diagnostic specialist Genoptix Inc., according to the Associated Press. Novartis will pay $25 per share to acquire
Read More

Shares of Generic Drugmaker Mylan Rise

The Associated Press reports, shares of Mylan Inc. jumped in trading, after the generic drugmaker said it received approval to make three doses of a generic version of Bayer''s
Read More

GlaxoSmithKline to Take $3.4 Billion Charge on Avandia

The Associated Press reports that GlaxoSmithKline PLC said Monday it will take a $3.4 billion charge against earnings in the fourth quarter to provide for litigation over its diabetes drug,
Read More

New 50-Inch Heavy-Duty Capsule Filter for Large Volume Filtration

New UltraCap® H.D. (Heavy Duty) single-use high-capacity capsule filter is now available in a 50-inch configuration for large volume filtration. The UltraCap® H.D. is optimized for continuous and batch processing
Read More

Oregon Attorney General Sues Johnson & Johnson

The Associated Press reports that Oregon Attorney General John Kroger has sued Johnson & Johnson and two subsidiaries, claiming consumers were exposed to defective supplies of Motrin by a delay
Read More

Lilly, Boehringer Collaborate on Diabetes Drugs

The Associated Press reports that Eli Lilly and Co. will team with German drugmaker Boehringer Ingelheim to develop diabetes treatments, as the U.S. pharmaceutical company pushes to fill a looming
Read More

Vibratory Loss-in-Weight Pharmaceutical Feeder for Gravimetric Feeding

Pharmaceutical feeder line has been expanded to include the K-PH-ML-D5-KV2, a vibratory loss-in-weight feeder designed for the low rate addition of difficult-flowing active pharmaceutical ingredients (APIs). Typical applications include vibratory
Read More

FDA Seeks More Time for Vandetanib Review

According to the Associated Press, AstraZeneca PLC said the U.S. Food and Drug Administration will take three more months to review the British company''s application for vandetanib, a drug it
Read More